Vanguard Personalized Indexing Management LLC Increases Stock Holdings in Cardinal Health, Inc. $CAH

Vanguard Personalized Indexing Management LLC boosted its position in shares of Cardinal Health, Inc. (NYSE:CAH) by 5.8% in the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 46,878 shares of the company’s stock after acquiring an additional 2,560 shares during the quarter. Vanguard Personalized Indexing Management LLC’s holdings in Cardinal Health were worth $9,633,000 at the end of the most recent quarter.

Other hedge funds and other institutional investors also recently bought and sold shares of the company. Nordea Investment Management AB boosted its holdings in Cardinal Health by 328.3% during the 4th quarter. Nordea Investment Management AB now owns 645,436 shares of the company’s stock valued at $133,741,000 after acquiring an additional 494,731 shares during the period. Victory Capital Management Inc. boosted its holdings in Cardinal Health by 44.9% during the 3rd quarter. Victory Capital Management Inc. now owns 2,284,115 shares of the company’s stock valued at $352,165,000 after acquiring an additional 707,495 shares during the period. Procyon Advisors LLC boosted its holdings in Cardinal Health by 78.7% during the 4th quarter. Procyon Advisors LLC now owns 17,025 shares of the company’s stock valued at $3,499,000 after acquiring an additional 7,499 shares during the period. Public Sector Pension Investment Board boosted its holdings in Cardinal Health by 66.7% during the 3rd quarter. Public Sector Pension Investment Board now owns 30,007 shares of the company’s stock valued at $4,710,000 after acquiring an additional 12,003 shares during the period. Finally, Sierra Summit Advisors LLC purchased a new position in shares of Cardinal Health in the 3rd quarter valued at about $9,897,000. 87.17% of the stock is currently owned by hedge funds and other institutional investors.

Wall Street Analyst Weigh In

A number of equities analysts have recently commented on the company. TD Cowen boosted their price objective on Cardinal Health from $251.00 to $255.00 and gave the stock a “buy” rating in a research report on Friday, May 1st. Barclays boosted their price objective on Cardinal Health from $243.00 to $258.00 and gave the stock an “overweight” rating in a research report on Tuesday, February 24th. Evercore lowered their price objective on Cardinal Health from $260.00 to $240.00 and set an “outperform” rating for the company in a research report on Wednesday, April 8th. Wells Fargo & Company lowered their price objective on Cardinal Health from $256.00 to $245.00 and set an “overweight” rating for the company in a research report on Friday, May 1st. Finally, Leerink Partners reissued an “outperform” rating and set a $275.00 price objective on shares of Cardinal Health in a research report on Monday, March 9th. One equities research analyst has rated the stock with a Strong Buy rating, fourteen have issued a Buy rating and two have issued a Hold rating to the company. Based on data from MarketBeat, Cardinal Health has an average rating of “Moderate Buy” and a consensus target price of $246.93.

Cardinal Health Stock Up 1.2%

CAH stock opened at $226.52 on Tuesday. The business has a 50 day moving average price of $203.46 and a 200 day moving average price of $208.92. The stock has a market cap of $53.05 billion, a price-to-earnings ratio of 34.64, a PEG ratio of 1.22 and a beta of 0.52. Cardinal Health, Inc. has a fifty-two week low of $137.75 and a fifty-two week high of $233.60.

Cardinal Health (NYSE:CAH) last posted its earnings results on Thursday, April 30th. The company reported $3.17 earnings per share for the quarter, topping the consensus estimate of $2.79 by $0.38. The firm had revenue of $60.94 billion during the quarter, compared to analysts’ expectations of $62.10 billion. Cardinal Health had a negative return on equity of 92.61% and a net margin of 0.62%.The firm’s revenue was up 11.0% compared to the same quarter last year. During the same quarter in the previous year, the business earned $2.35 earnings per share. Cardinal Health has set its FY 2026 guidance at 10.700-10.80 EPS. As a group, sell-side analysts anticipate that Cardinal Health, Inc. will post 10.76 EPS for the current year.

Cardinal Health Increases Dividend

The firm also recently announced a quarterly dividend, which will be paid on Wednesday, July 15th. Investors of record on Wednesday, July 1st will be paid a dividend of $0.5158 per share. The ex-dividend date is Wednesday, July 1st. This is a positive change from Cardinal Health’s previous quarterly dividend of $0.51. This represents a $2.06 annualized dividend and a yield of 0.9%. Cardinal Health’s dividend payout ratio (DPR) is presently 31.19%.

About Cardinal Health

Cardinal Health is a multinational healthcare services and products company headquartered in Dublin, Ohio. Tracing its roots to the early 1970s, the company has grown into a major provider of supply chain and distribution services for the healthcare sector. Cardinal Health operates across a range of service lines that support hospitals, health systems, pharmacies, physician offices and clinical laboratories.

The company’s core activities include the wholesale distribution of branded and generic pharmaceuticals, the supply and distribution of medical-surgical products, and the provision of logistics and inventory management solutions.